Vivanza Biosciences Ltd Financial Ratios
VIVANZA · Healthcare · Current price ₹1.69
P/E ratio
16.9x
P/B ratio
1.7x
ROE
9.0%
ROCE
5.7%
Debt / Equity
2.34
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 16.9x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.7x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 9.0% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 5.7% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 2.34 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Vivanza Biosciences Ltd's latest numbers.
Vivanza Biosciences Ltd profitability
Vivanza Biosciences Ltd generates a return on equity of 9.0% and a return on capital employed of 5.7%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 2.34 and a P/E of 16.9x, Vivanza Biosciences Ltd is carrying meaningful debt. Our overall business-quality score for the company is 3.1 / 10.
Understand the ratios
More on Vivanza Biosciences Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.